There may be one more on the agenda coming up and nothing is in concrete yet. Hospira is known for being one of the few manufacturers of propofol. BD
Hospira a Midwestern pharmaceutical and medical device maker, is in talks to pay about $5 billion for the medical nutrition business of the French consumer group Danone, a person briefed on the matter said.
The deal, if completed, would allow Hospira to reincorporate overseas in a so-called inversion, lowering its tax rate and freeing its foreign cash.
Hospira, based in Lake Forest, Ill., has a market value of $8.6 billion and makes a range of drugs, pumps and software for the medical industry. The person briefed on the negotiations said they were continuing and could fail. The Financial Times on Sunday reported on the talks.
If completed, Hospira’s deal with Danone could be considered a “spinversion,” in which a foreign company spins off a unit to an American buyer, allowing it to undertake an inversion.